By Marius Meland ( May 11, 2004, 12:00 AM EDT) -- Cephalon Inc. said in a regulatory filing to the U.S. Securities and Trade Commission that it plans to sue Sandoz Inc. over its Abbreviated New Drug Application (ANDA) for a generic form of modafinil, the active drug substance in its narcolepsy drug Provigil....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.